Works matching DE "DRUG efficacy"
Results: 5000
Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 3, p. 7
- By:
- Publication type:
- Article
Reassessments of ESAs for Cancer Treatment in the US and Europe.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 3, p. 260
- By:
- Publication type:
- Article
HDAC Inhibitors in Cancer Care.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 180
- By:
- Publication type:
- Article
Phase III Data Show Octreotide Reduced Risk of Disease Progression by 66% in Advanced Neuroendocrine Tumor Patients.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 12, p. 1104
- Publication type:
- Article
Pazopanib Approved for Advanced Kidney Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 12, p. 1009
- Publication type:
- Article
Bendamustine Study Demonstrates Significant Improvement in Overall Response and Progression- Free Survival in CLL Patients.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 850
- Publication type:
- Article
Letrozole Superior to Tamoxifen After Breast Cancer Surgery, According to New Data.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 850
- Publication type:
- Article
FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 810
- Publication type:
- Article
Accelerated Approval Granted for Bevacizumab in Glioblastoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 810
- Publication type:
- Article
Maintenance Therapy With Pemetrexed Improves Overall Survival in Advanced NSCLC.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 638
- Publication type:
- Article
Therapeutic Cancer Vaccine Significantly Prolongs Disease-Free Survival for Follicular Lymphoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 642
- Publication type:
- Article
Important Considerations in LHRH Antagonist Therapy for Prostate Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 636
- By:
- Publication type:
- Article
Alemtuzumab May Lead to Longer Overall Survival in CLL Patients With Poor Prognostic Factors.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 14, p. 1632
- Publication type:
- Article
Rituximab, Fludarabine, and Cyclophosphamide Prolongs Progression-Free Survival in Relapsed or Refractory Chronic Lymphocytic Leukemia.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 14, p. 1578
- Publication type:
- Article
Sorafenib Study Demonstrates Significant Improvement in Overall Survival in Liver Cancer Patients.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 9, p. 970
- Publication type:
- Article
New Data Support the Efficacy and Safety Profile of Single-Agent Sunitinib in the Treatment of Imatinib-Resistant GIST.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 8, p. 962
- Publication type:
- Article
Sorafenib Significantly Improves Overall Survival in Asia-Pacific Liver Cancer Study.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 8, p. 860
- Publication type:
- Article
Bortezomib-Based Treatment Produces Impressive Complete Response and Survival in Newly Diagnosed Multiple Myeloma.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 8, p. 860
- Publication type:
- Article
Critical Questions About Rituximab Maintenance in Lymphoma Patients.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 1, p. 26
- By:
- Publication type:
- Article
Updated Study Results Reinforce Survival Benefit of Docetaxel for Men With Advanced, Hormone-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1143
- Publication type:
- Article
Lenalidomide Data in Multiple Myeloma Patients Demonstrate Impressive Survival Benefit.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1143
- Publication type:
- Article
Hepatocellular Carcinoma Patients Awaiting Transplant: General Guidelines for Management.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1127
- By:
- Publication type:
- Article
Hepatocellular Carcinoma: Neoadjuvant Therapy Reconsidered.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1122
- By:
- Publication type:
- Article
Neoadjuvant Therapy for Hepatocellular Carcinoma: Is There an Optimal Approach?
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1116
- By:
- Publication type:
- Article
One Moment in Research.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 8, p. 1028
- By:
- Publication type:
- Article
Monoclonal Antibodies to EGFR: What Does the Future Hold?
- Published in:
- Oncology (08909091), 2007, v. 21, n. 8, p. 976
- By:
- Publication type:
- Article
New Data Show Cervical Cancer Vaccine Provided Significant Protection Through 3 Years.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 889
- Publication type:
- Article
Cryoablation at Least as Effective as External-Beam Radiation for Treating Localized Prostate Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 886
- Publication type:
- Article
Study Continues to Show MDS Patients Treated With Lenalidomide Are Living Longer and Remaining Transfusion-Independent.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 886
- Publication type:
- Article
A New Era in the Management of Multiple Myeloma.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 800
- By:
- Publication type:
- Article
Lenalidomide Plus Low-Dose Dexamethasone Produces Survival Advantage in Multiple Myeloma.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 5, p. 616
- Publication type:
- Article
Protein-Bound Paclitaxel Promising as First-Line Treatment in Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 936
- Publication type:
- Article
Interim Data Suggest Potential Benefits of Darbepoetin Dosed Every 3 Weeks With Intravenous Iron.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 936
- Publication type:
- Article
Imatinib Sets New Treatment Standard in Patients With Chronic Myeloid Leukemia.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 935
- Publication type:
- Article
Temsirolimus Prolongs Survival of Patients With Advanced Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 934
- Publication type:
- Article
Updated Overall Survival Analysis Presented on Sorafenib Trial.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 934
- Publication type:
- Article
Bevacizumab/Chemo Combination Approved for Treating Metastatic Colorectal Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 942
- Publication type:
- Article
Anastrozole Does Not Cause Osteoporosis in Breast Cancer Patients With Normal Bone Mineral Density at Outset.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 941
- Publication type:
- Article
Capecitabine/Cisplatin Effective in Advanced Gastric Cancer Patients.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 814
- Publication type:
- Article
Sunitinib Proves Beneficial in Advanced Kidney Cancer, Promising in Lung Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 812
- Publication type:
- Article
Lapatinib Nearly Doubles Time to Progression for Patients With HER2-Positive Advanced Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 812
- Publication type:
- Article
PROs: Defining Clinical Benefit From the Patient's Perspective.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 6, p. 660
- By:
- Publication type:
- Article
Is There New Hope for MDS?
- Published in:
- 2006
- Publication type:
- Abstract
WHAM evidence summary: topical turmeric for wound healing.
- Published in:
- World Council of Enterostomal Therapists Journal, 2022, v. 42, n. 3, p. 38, doi. 10.33235/wcet.42.3.38-41
- By:
- Publication type:
- Article
WHAM evidence summary: Aloe vera for treating burns.
- Published in:
- World Council of Enterostomal Therapists Journal, 2022, v. 42, n. 2, p. 36, doi. 10.33235/wcet.42.2.36-39
- By:
- Publication type:
- Article
Saline Versus Heparin in Intermittent Infuser Patency Maintenance.
- Published in:
- Western Journal of Nursing Research, 1992, v. 14, n. 2, p. 131, doi. 10.1177/019394599201400202
- By:
- Publication type:
- Article
Do Financial Conflicts of Inteterest Bias Research?: An Inquiry into the “Funding Effect” Hypothesis.
- Published in:
- Science, Technology & Human Values, 2013, v. 38, n. 4, p. 566, doi. 10.1177/0162243912456271
- By:
- Publication type:
- Article
Olaparib/pembrolizumab, focal therapy, and ultrasonic propulsion of stones: AUA 2021 highlights.
- Published in:
- 2021
- By:
- Publication type:
- Proceeding
Adding pharmacotherapy to behavioral modification is not beneficial for nocturia.
- Published in:
- Urology Times, 2021, v. 49, n. 8, p. 12
- By:
- Publication type:
- Article
Pembrolizumab/axitinib RCC survival bene?t is sustained in long-term results: Median OS was 45.7 months with the combination vs 40.1 months with sunitinib.
- Published in:
- Urology Times, 2021, v. 49, n. 7, p. 17
- By:
- Publication type:
- Article